1[1]Pinette M, Katz W, Drouin M, et al. Successful planned pregnancy following endometrial ablation with the YAG laser. Am J Obstet Gynecol, 2001,185:242-243.
2[3]Fujiwaki R, Iida K, Kanasaki H. Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase. Hum Pathol, 2002, 33:213-219.
3[4]Nayak N, Brenner R. Vascular proliferation and Vascular Endothelial Growth Factor expression in the Rhesus Macaque endometrium. J Clin Endocrin & Metab, 2002, 87: 1845-1855.
4[5]Charnock-Jones DS, Macpherson AM, Archer DF. The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium. Hum Reprod, 2000,15:85-95.
5[6]Mohamed Shaarawy, Sherif A. Biomarkers of intrinsic angiogenic and anti-angiogenic activity in patients with endometrial hyperplasia and endometrial cancer. Acta Oncologica, 2001, 40:513-518.
6[7]Rak J, Mitsuhashi Y. Oncogenes and tumor angiogenesis: differentical modes of vascular endothelial growth factor up regulation in ras-transformed epithelial cells and fibrobasts. Cancer Res, 2000, 60:490-492.
7[8]Duda DG, Sumamura M, Lozonschi L, et al. Direct in vitro evidence and in vivo analysis of the antiangiogenesis effect of interleukin. Cancer Res, 2000, 60:111-114.
8[1]Glacvcckc L.Krpcrliche UND gcistige ver nderungcn im weiblichen krpcr nach künstlichem verlust der ovarim cinerseits und uterus andererseits.Arch Gynackok,1989,35:1.
9[4]Arulkumaran S.Prophylactic Oophorectomy:A Continuing Controversy.Obstetrical and Gynecological Survey,1998,53:493-499.
10[5]Naz RK,Thurston D,Santoro N.Circulating tumor necrosis factor(TNF)-alpha in normally cycling women and patients with premature ovarian failure and polycystic ovaries.Am J Reprod I mmunol,1995,34:170-175.
